Search research articles
Contact Us
Filters
Showing results (351-360 of 373) with videos related to
Page
of 38
Sort By:
Acta Dermato-Venereologica
|
November 20, 2019
Psoriasis and Mental Health Workshop Report: Exploring the Links between Psychosocial Factors, Psoriasis, Neuroinflammation and Cardiovascular Disease Risk
C Elise Kleyn, Peter S Talbot, Nehal N Mehta, et al.
Annals of Internal Medicine
|
December 19, 2012
Adalimumab for the treatment of moderate to severe Hidradenitis suppurativa: a parallel randomized trial
Alexa B Kimball, Francisco Kerdel, David Adams, et al.
The Journal of Experimental Medicine
|
November 1, 2006
IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2-dependent mechanisms with implications for psoriasis pathogenesis
Jason R Chan, Wendy Blumenschein, Erin Murphy, et al.
The Journal of Investigative Dermatology
|
December 10, 2021
Aging-Associated Changes in the Adult Human Skin Microbiome and the Host Factors that Affect Skin Microbiome Composition
Brian Howard, Charles C Bascom, Ping Hu, et al.
International Journal of General Medicine
|
January 14, 2021
Impact of Endometriosis on Life-Course Potential: A Narrative Review
Stacey A Missmer, Frank F Tu, Sanjay K Agarwal, et al.
The British Journal of Dermatology
|
November 29, 2024
Long-term efficacy and safety of secukinumab in patients with moderate-to-severe hidradenitis suppurativa: week 104 results from the SUNSHINE and SUNRISE extension trial
Alexa B Kimball, Falk G Bechara, Aysha Badat, et al.
Journal of the American Academy of Dermatology
|
November 17, 2025
Bimekizumab demonstrated a favorable safety profile and high levels of efficacy with up to 2 years of treatment in patients with moderate to severe hidradenitis suppurativa: Pooled results from two phase 3 randomized, controlled trials and their open-label extension
Christopher J Sayed, Brian Kirby, Amit Garg, et al.
Journal of the American Academy of Dermatology
|
March 16, 2019
North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part I: Diagnosis, evaluation, and the use of complementary and procedural management
Ali Alikhan, Christopher Sayed, Afsaneh Alavi, et al.
JAMA Dermatology
|
October 17, 2012
Topical chemotherapy in cutaneous T-cell lymphoma: positive results of a randomized, controlled, multicenter trial testing the efficacy and safety of a novel mechlorethamine, 0.02%, gel in mycosis fungoides
Stuart R Lessin, Madeleine Duvic, Joan Guitart, et al.
Journal of the American Academy of Dermatology
|
March 16, 2019
North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part II: Topical, intralesional, and systemic medical management
Ali Alikhan, Christopher Sayed, Afsaneh Alavi, et al.
Page
of 38
Search research articles
Search
Showing results (351-360 of 373) with videos related to
Sort By:
Page
of 38
Acta Dermato-Venereologica
|
November 20, 2019
Psoriasis and Mental Health Workshop Report: Exploring the Links between Psychosocial Factors, Psoriasis, Neuroinflammation and Cardiovascular Disease Risk
C Elise Kleyn, Peter S Talbot, Nehal N Mehta, et al.
Annals of Internal Medicine
|
December 19, 2012
Adalimumab for the treatment of moderate to severe Hidradenitis suppurativa: a parallel randomized trial
Alexa B Kimball, Francisco Kerdel, David Adams, et al.
The Journal of Experimental Medicine
|
November 1, 2006
IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2-dependent mechanisms with implications for psoriasis pathogenesis
Jason R Chan, Wendy Blumenschein, Erin Murphy, et al.
The Journal of Investigative Dermatology
|
December 10, 2021
Aging-Associated Changes in the Adult Human Skin Microbiome and the Host Factors that Affect Skin Microbiome Composition
Brian Howard, Charles C Bascom, Ping Hu, et al.
International Journal of General Medicine
|
January 14, 2021
Impact of Endometriosis on Life-Course Potential: A Narrative Review
Stacey A Missmer, Frank F Tu, Sanjay K Agarwal, et al.
The British Journal of Dermatology
|
November 29, 2024
Long-term efficacy and safety of secukinumab in patients with moderate-to-severe hidradenitis suppurativa: week 104 results from the SUNSHINE and SUNRISE extension trial
Alexa B Kimball, Falk G Bechara, Aysha Badat, et al.
Journal of the American Academy of Dermatology
|
November 17, 2025
Bimekizumab demonstrated a favorable safety profile and high levels of efficacy with up to 2 years of treatment in patients with moderate to severe hidradenitis suppurativa: Pooled results from two phase 3 randomized, controlled trials and their open-label extension
Christopher J Sayed, Brian Kirby, Amit Garg, et al.
Journal of the American Academy of Dermatology
|
March 16, 2019
North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part I: Diagnosis, evaluation, and the use of complementary and procedural management
Ali Alikhan, Christopher Sayed, Afsaneh Alavi, et al.
JAMA Dermatology
|
October 17, 2012
Topical chemotherapy in cutaneous T-cell lymphoma: positive results of a randomized, controlled, multicenter trial testing the efficacy and safety of a novel mechlorethamine, 0.02%, gel in mycosis fungoides
Stuart R Lessin, Madeleine Duvic, Joan Guitart, et al.
Journal of the American Academy of Dermatology
|
March 16, 2019
North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part II: Topical, intralesional, and systemic medical management
Ali Alikhan, Christopher Sayed, Afsaneh Alavi, et al.
Page
of 38